Abstract
Introduction: The objectives of this study were to determine the participation rates, levels of engagement, and abilities to answer User eXperience (UX) questionnaires according to the presence and severity of major neurocognitive disorders (MNCD) among participants involved in gerontechnological experimentations within a hospital-based geriatric clinical living lab. Methods: Cross-sectional analysis examining all consecutive geriatric patients involved in the Allegro living lab experimentations, separated according to the presence and severity of MNCD. Participation rates were assessed using the “Task-Based Experiment”-type User eXperience (TBE-UX). Participation was considered successful if patients fully completed the TBE-UX experimental procedure. Engagement level was characterized using a five-point scale: interactive, constructive, active, passive, and disengaged. The abilities to answer UX questionnaires were characterized using a five-point scale from “no completion” to “completion in autonomy.” Results: 313 patients were included. All patients without MNCD and with mild MNCD fully completed the TBE-UX procedures. Their engagement behaviors were rather active and constructive. All patients without MNCD and 88% of those with mild MNCD were able to fully complete the UX questionnaires. 96.2% of the patients with moderate MNCD fully followed the TBE-UX procedures. Their engagement behaviors were mainly active or passive. 64.2% were able to fully complete the UX questionnaires. 76.5% of the patients with severe MNCD fully followed the TBE-UX procedures. Their engagement behaviors were mainly passive or disengaged. 35.3% were able to fully complete the UX questionnaires. Conclusion: Living lab experimentations appear feasible with older adults, even with those with MNCD. Task support can be offered to those with severe MNCD.
Journal Section:
Research Article
References
1.
World Health Organization
. World report on ageing and health 2015
; 2015
. Available from: https://www.who.int/publications/i/item/97892415650422.
Broussy
L
. L’adaptation de la société au vieillissement de sa population: France, année zéro
. Ministère de la Santé et de la Prévention
; 2013
; p. 202
.3.
Sacco
G
, Noublanche
F
, Blazek
F
, Hue
C
, Carballido
L
, Asfar
M
, et al. How to deal with the consent of adults with cognitive impairment involved in European geriatric living labs
. Philos Ethics Humanit Med
. 2021
;16
(1
):3
. 4.
Annweiler
C
, Noublanche
F
, Jaglin-Grimonprez
C
, Bubien
Y
. Built environments for frail older adults: the now and next
. Maturitas
. 2018
;116
:137
–8
. 5.
Dubé
P
, Sarrailh
J
, Grillet
C
, Billebaud
C
, Zingraff
V
, Kostecki
I
. Le livre blanc des Living Labs
. UMVELT & Montréal Invivo
; 2014
. p. 133
. Available from: https://www.montreal-invivo.com/wp-content/uploads/2019/12/livre-blanc-ll-umvelt-final-mai-2014.pdf6.
Park
Y
, Go
TH
, Hong
SH
, Kim
SH
, Han
JH
, Kang
Y
, et al. Digital biomarkers in living labs for vulnerable and susceptible individuals: an integrative literature review
. Yonsei Med J
. 2022
;63
(Suppl l
):S43
–55
. 7.
Noublanche
F
, Jaglin-Grimonprez
C
, Laignel
L
, Sacco
G
, Allain
P
, Annweiler
C
, et al. Adapting gerontechnological development to hospitalized frail older people: implementation of the ALLEGRO hospital-based geriatric living lab
. J Am Med Dir Assoc
. 2020
;21
(4
):550
–4
. 8.
Noublanche
F
, Jaglin-Grimonprez
C
, Sacco
G
, Lerolle
N
, Allain
P
, Annweiler
C
, et al. The development of gerontechnology for hospitalized frail elderly people: the ALLEGRO hospital-based geriatric living lab
. Maturitas
. 2019
;125
:17
–9
. 9.
Noublanche
F
. ALLeGRO, a constructive partnership around gerontechnologies
. Soins Gerontol
. 2022
;27
(153
):10
–3
. 10.
Dhouib
A
, Trabelsi
A
, Kolski
C
, Neji
M
. A classification and comparison of usability evaluation methods for interactive adaptive systems
. 2016 9th international conference on human system interactions (HSI). 2016
. p. 246
–51
.11.
Salvendy
G
. Handbook of human factors and ergonomics
. John Wiley & Sons
; 2012
; p. 1754
.12.
Lallemand
C
, Gronier
G
. Méthodes de design UX: 30 méthodes fondamentales pour concevoir et évaluer les systèmes interactifs
. 1er ed.. Paris
: Eyrolles
; 2015
; p. 488
.13.
International Organization for Standardization
. ISO 9241-11:2018, ergonomics of human-system interaction – Part 11: usability: definitions and concepts
; 2018
[cited 2022 Nov 5]. Available from: https://www.iso.org/obp/ui/#iso:std:63500:en14.
Timmons
S
, Manning
E
, Barrett
A
, Brady
NM
, Browne
V
, O’Shea
E
, et al. Dementia in older people admitted to hospital: a regional multi-hospital observational study of prevalence, associations and case recognition
. Age Ageing
. 2015
;44
(6
):993
–9
. 15.
Beltramo
C
, Potentier
S
, Pourcelle
P
, Dartinet
V
, Jego
A
, Kadri
N
. Profil neuropsychologique des patients âgés hospitalisés: Etude prospective dans des unités de court et moyen séjour gériatriques
. NPG Neurologie - Psychiatrie - Gériatrie
. 2005
;5
(29
):7
–12
. 16.
Begde
A
, Jain
M
, Goodwin
M
, Brayne
C
, Barnes
L
, Brooks
R
, et al. Exploring factors influencing willingness of older adults to use assistive technologies: evidence from the cognitive function and ageing study II
. Inf Commun Soc
. 2023
;27
(2
):368
–85
. 17.
Contreras-Somoza
LM
, Irazoki
E
, Toribio-Guzmán
JM
, de la Torre-Díez
I
, Diaz-Baquero
AA
, Parra-Vidales
E
, et al. Usability and user experience of cognitive intervention technologies for elderly people with MCI or dementia: a systematic review
. Front Psychol
. 2021
;12
:636116
. 18.
Lio
G
, Fadda
R
, Doneddu
G
, Duhamel
JR
, Sirigu
A
. Digit-tracking as a new tactile interface for visual perception analysis
. Nat Commun
. 2019
;10
(1
):5392
. 19.
American Psychiatric Association
. Diagnostic and statistical manual of mental disorders (DSM-5®)
. American Psychiatric Publishing
; 2013
; p. 1505
.20.
Folstein
MF
, Folstein
SE
, McHugh
PR
. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
. J Psychiatr Res
. 1975
;12
(3
):189
–98
. 21.
National Solidarity Fund for Autonomy, Ministry of social affairs
. Comment fonctionne la grille AGGIR
. 2022
. Available from: https://www.pour-les-personnes-agees.gouv.fr/preserver-son-autonomie-s-informer-et-anticiper/perte-d-autonomie-evaluation-et-droits/comment-fonctionne-la-grille-aggir22.
Coutton
V
. Évaluer la dépendance à l’aide de groupes iso-ressources (GIR): une tentative en France avec la grille aggir
. Gerontologie et societe
. 2001
;24
(99
):111
–29
. 23.
Katz
S
, Ford
AB
, Moskowitz
RW
, Jackson
BA
, Jaffe
MW
. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function
. JAMA
. 1963
;185
:914
–9
. 24.
Pérès
K
, Brayne
C
, Matharan
F
, Grasset
L
, Helmer
C
, Letenneur
L
, et al. Trends in prevalence of dementia in French farmers from two epidemiological cohorts
. J Am Geriatr Soc
. 2017
;65
(2
):415
–20
. 25.
Chi
MTH
, Wylie
R
. The ICAP framework: linking cognitive engagement to active learning outcomes
. Educ Psychol
. 2014
;49
(4
):219
–43
. 26.
Chi
MTH
, Adams
J
, Bogusch
EB
, Bruchok
C
, Kang
S
, Lancaster
M
, et al. Translating the ICAP theory of cognitive engagement into practice
. Cogn Sci
. 2018
;42
(6
):1777
–832
. 27.
Chi
MTH
. Active-constructive-interactive: a conceptual framework for differentiating learning activities
. Top Cogn Sci
. 2009
;1
(1
):73
–105
. 28.
Antonietti
C
, Schmitz
ML
, Consoli
T
, Cattaneo
A
, Gonon
P
, Petko
D
. Development and validation of the ICAP technology scale to measure how teachers integrate technology into learning activities
. Comput Educ
. 2023
;192
:104648
. 29.
Hassenzahl
M
. The interplay of beauty, goodness, and usability in interactive products
. Hum Comput Interact
. 2004
;19
(4
):319
–49
. 30.
Lallemand
C
, Koenig
V
, Gronier
G
, Martin
R
. Création et validation d’une version française du questionnaire AttrakDiff pour l’évaluation de l’expérience utilisateur des systèmes interactifs
. Eur Rev Appl Psychol
. 2015
;65
(5
):239
–52
. 31.
Minge
M
, Thüring
M
, Wagner
I
. Developing and validating an English version of the meCUE questionnaire for measuring user experience
. Proc Hum Factors Ergon Soc Annu Meet
. 2016
;60
(1
):2063
–7
. 32.
Lallemand
C
, Koenig
V
. How could an intranet be like a friend to me? Why standardized UX scales don’t always fit
. Proceedings of the European Conference on Cognitive Ergonomics [Internet]. New York, NY, USA
: Association for Computing Machinery
; 2017
. p. 9
–16
.33.
Wekerle
C
, Daumiller
M
, Kollar
I
. Using digital technology to promote higher education learning: the importance of different learning activities and their relations to learning outcomes
. J Res Technol Educ
. 2022
;54
(1
):1
–17
. 34.
Khalili-Mahani
N
, Sawchuk
K
. Double-bind of recruitment of older adults into studies of successful aging via assistive information and communication technologies: mapping review
. JMIR Aging
. 2022
;5
(4
):e43564
. 35.
Goodwin
VA
, Low
MSA
, Quinn
TJ
, Cockcroft
EJ
, Shepherd
V
, Evans
PH
, et al. Including older people in health and social care research: best practice recommendations based on the INCLUDE framework
. Age Ageing
. 2023
;52
(6
):afad082
. 36.
McHenry
JC
, Insel
KC
, Einstein
GO
, Vidrine
AN
, Koerner
KM
, Morrow
DG
. Recruitment of older adults: success may be in the details
. Gerontologist
. 2015
;55
(5
):845
–53
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
